MedPath

One-month Clinical Evaluation of Silicone Hydrogel Definitive 65 HPT Contact Lenses

Not Applicable
Completed
Conditions
Ametropia
Interventions
Device: Definitive 65 HPT contact lenses
Device: Definitive 65 contact lenses
Registration Number
NCT02312323
Lead Sponsor
Contamac Ltd
Brief Summary

Comparison of different contact lens materials.

Detailed Description

This is a 1-month, open-label, bilateral, parallel-group, randomised, daily wear study. Two-thirds of the subjects will wear the Test lenses in both eyes, and one-third will wear the Control lenses in both eyes.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
35
Inclusion Criteria
  • willing and able to sign informed consent form
  • ages 18 years or older
  • Subjects must have owned spectacles or contact lenses prior to enrolment for this trial
  • Spherical power between -10.00 D and +10.00 D (at vertex distance 0 mm)
  • Astigmatic power ≤0.75 D
Exclusion Criteria
  • Eye injury or surgery within 3 months immediately prior to enrolment for this trial
  • Pre-existing ocular irritation that would preclude contact lens fitting
  • Currently enrolled in an ophthalmic clinical trial
  • Evidence of systemic or ocular abnormality, infection or disease which is likely to affect successful wear of contact lenses or use of the accessory solutions, as determined by the investigator
  • Any use of medications for which contact lens wear could be contradicted, as determined by the investigator
  • Current extended-wear users (sleep-in overnight)
  • Current monovision lens wearers
  • Pregnant women and nursing mothers
  • Best-corrected visual acuity worse than 6/9 (LogMAR: +0.20; Snellen decimal: 0.63)

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Definitive 65 HPTDefinitive 65 HPT contact lensesThe Test product were the Definitive 65 (Filcon V4) lenses with Hydra PEG surface coating. This material is produced by Contamac Ltd. and the contact lenses were manufactured by Appenzeller Kontaktlinsen AG.
Definitive 65Definitive 65 contact lensesThe Control product was the commercially available Definitive 65 (Efrofilcon A) lens. This material is produced by Contamac Ltd. and the contact lenses were manufactured by Appenzeller Kontaktlinsen AG.
Primary Outcome Measures
NameTimeMethod
corneal staining - ocular biomicroscopysubjects will be followed-up for one month

Assessed using slit lamp with white light, low-medium magnification. Graded based on a grading scale which ranged from 0 to 4, where 0 is none, 1 is trace, 2 is mild, 3 is moderate and 4 is severe.

questionnaire addressing subjective comfort and wear timesubjects will be followed-up for one month

Subjects rated on a scale from 1 to 10, where 1 was 'poor' and 10 was 'excellent'.

limbal redness - ocular biomicroscopysubjects will be followed-up for one month

Assessed using slit lamp with white light, low-medium magnification. Graded based on a grading scale which ranged from 0 to 4, where 0 is none, 1 is trace, 2 is mild, 3 is moderate and 4 is severe.

conjunctival redness - ocular biomicroscopysubjects will be followed-up for one month

Assessed using slit lamp with white light, low-medium magnification. Graded based on a grading scale which ranged from 0 to 4, where 0 is none, 1 is trace, 2 is mild, 3 is moderate and 4 is severe.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (2)

Kresinky

🇩🇪

Würzburg, Germany

Siehste

🇩🇪

Kassel, Germany

© Copyright 2025. All Rights Reserved by MedPath